Grand Pharmaceutical Group Limited (0512.HK, "Grand Pharma" or the "Group") announces that the Phase II clinical study for the treatment of sepsis in China of the global innovative drug STC3141, which ...

For the primary endpoint -- mean change in Sequential Organ Failure Assessment (SOFA) score between day 0 and 7 or the day of ...